Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-09-27

FDA Approved: IRBESARTAN — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a generic irbesartan product from Camber Pharmaceuticals through an original ANDA. The product is indicated for hypertension and diabetic nephropat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Irbesartan (irbesartan)

Snippet

ORIG AP for IRBESARTAN (IRBESARTAN)